Skip to the page

Data / Form D filings / Native Cardio, Inc.

Native Cardio, Inc.: Form D filings

Native Cardio, Inc., a biotechnology company in Naples, FL, filed 6 Form D notices with the SEC between 2019 and 2025. The latest, on March 5, 2025, reports $150,000 sold of a $1 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
868 106TH AVENUE N, SUITE 8, Naples, FL, 34108
Phone
(239) 908-4446
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1767312

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 5, 2025New notice$1,000,000$150,000$850,0001Feb 25, 2025sec.gov
Mar 1, 2023Amendment$5,000,000$465,000$4,535,0007May 6, 2021sec.gov
May 11, 2021New notice$2,000,000$70,000$1,930,0002May 6, 2021sec.gov
Jan 26, 2021Amendment$6,000,000$2,500,241$3,499,7595Feb 8, 2019sec.gov
Jan 29, 2020Amendment$6,000,000$2,150,101$3,849,8994Feb 8, 2019sec.gov
Feb 12, 2019New notice$6,000,000$1,999,956$4,000,0442Feb 8, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joseph V. PergolizziExecutive Officer, Director
Young D. KimDirector
Myles P. Dempsey, Sr.Director

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Mar 3, 2025 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Native Cardio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.